SAN FRANCISCO, September 17, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will present at the Cantor Global Healthcare Conference on October 1 and the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 in New York City. Denise Bevers, Co-Founder and Chief Operating Officer, will […]
/wp-content/uploads/2017/09/KindredBioHeader2017.png00Katja Buhrer/wp-content/uploads/2017/09/KindredBioHeader2017.pngKatja Buhrer2018-09-17 08:33:442018-09-17 08:33:44Kindred Biosciences to Present at Cantor Global Healthcare Conference and Ladenburg Thalmann 2018 Healthcare Conference
SAN FRANCISCO, August 30, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the LD Micro San Francisco Summit taking place September 4th, the CL King 16th Annual Best Ideas Conference and the Lake Street Capital Markets 2nd Annual Best Ideas Growth Conference, both […]
/wp-content/uploads/2017/09/KindredBioHeader2017.png00Katja Buhrer/wp-content/uploads/2017/09/KindredBioHeader2017.pngKatja Buhrer2018-08-30 08:33:502018-08-30 08:33:50Kindred Biosciences to Participate in the CL King 16th Annual Best Ideas Conference, Lake Street Capital Markets 2nd Annual Best Ideas Growth Conference and LD Micro San Francisco Summit
SAN FRANCISCO, August 21, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the B. Riley FBR Annual Healthcare Conference being held on September 4th in New York at the New York Marriott East Side. Denise Bevers, Co-Founder and Chief Operating Officer, will be […]
/wp-content/uploads/2017/09/KindredBioHeader2017.png00Russell Radefeld/wp-content/uploads/2017/09/KindredBioHeader2017.pngRussell Radefeld2018-08-21 08:35:152018-08-21 08:36:15Kindred Biosciences to Participate in the B. Riley FBR Annual Healthcare Conference
San Francisco, CA (August 9, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2018 and provided updates on its programs. “We are encouraged so far by the response from veterinarians, distributors, and cat […]
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, August 9, 2018 San Francisco, CA (July 16, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its second quarter […]
0.87 (7.12%)
Kindred Biosciences to Present at Cantor Global Healthcare Conference and Ladenburg Thalmann 2018 Healthcare Conference
/in Frontpage, Investor, News /by Katja BuhrerSAN FRANCISCO, September 17, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will present at the Cantor Global Healthcare Conference on October 1 and the Ladenburg Thalmann 2018 Healthcare Conference on October 2, 2018 in New York City. Denise Bevers, Co-Founder and Chief Operating Officer, will […]
Kindred Biosciences to Participate in the CL King 16th Annual Best Ideas Conference, Lake Street Capital Markets 2nd Annual Best Ideas Growth Conference and LD Micro San Francisco Summit
/in Frontpage, Investor, News /by Katja BuhrerSAN FRANCISCO, August 30, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the LD Micro San Francisco Summit taking place September 4th, the CL King 16th Annual Best Ideas Conference and the Lake Street Capital Markets 2nd Annual Best Ideas Growth Conference, both […]
Kindred Biosciences to Participate in the B. Riley FBR Annual Healthcare Conference
/in Frontpage, Investor, News /by Russell RadefeldSAN FRANCISCO, August 21, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, will participate in the B. Riley FBR Annual Healthcare Conference being held on September 4th in New York at the New York Marriott East Side. Denise Bevers, Co-Founder and Chief Operating Officer, will be […]
Kindred Biosciences Announces Second Quarter 2018 Financial Results
/in Frontpage, Investor, News /by Russell RadefeldSan Francisco, CA (August 9, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2018 and provided updates on its programs. “We are encouraged so far by the response from veterinarians, distributors, and cat […]
Kindred Biosciences to Announce Second Quarter 2018 Financial Results
/in Frontpage, Investor, News /by Russell RadefeldCompany to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Thursday, August 9, 2018 San Francisco, CA (July 16, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, today announced that it will release its second quarter […]